We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.59B
AUM Growth
-$78.5M
Cap. Flow
-$53.5M
Cap. Flow %
-1.49%
Top 10 Hldgs %
13.47%
Holding
1,643
New
159
Increased
579
Reduced
611
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$52.5M
2
AFL icon
Aflac
AFL
+$24.1M
3
WLY icon
John Wiley & Sons Class A
WLY
+$18.9M
4
KMX icon
CarMax
KMX
+$17.5M
5
BIIB icon
Biogen
BIIB
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.39%
2 Energy 10.37%
3 Financials 10.35%
4 Technology 9.89%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WM icon
101
Waste Management
WM
$90.9B
$7.95M 0.22%
171,505
-13,974
-8% -$703K
VLO icon
102
Valero Energy
VLO
$92.6B
$7.94M 0.22%
126,812
+9,614
+8% +$568K
WPX
103
DELISTED
WPX Energy, Inc.
WPX
$7.92M 0.22%
644,835
+31,746
+5% +$418K
ELV icon
104
Elevance Health
ELV
$81.6B
$7.84M 0.22%
47,751
+4,693
+11% +$750K
MS icon
105
Morgan Stanley
MS
$330B
$7.74M 0.22%
199,495
+8,114
+4% +$309K
CMI icon
106
Cummins
CMI
$87.3B
$7.59M 0.21%
57,827
+659
+1% +$90.6K
HRB icon
107
H&R Block
HRB
$5.61B
$7.58M 0.21%
255,576
+26,873
+12% +$843K
ENLK
108
DELISTED
EnLink Midstream Partners, LP
ENLK
$7.53M 0.21%
342,574
+155,565
+83% +$3.85M
CHD icon
109
Church & Dwight Co
CHD
$23.1B
$7.49M 0.21%
184,550
-14,768
-7% -$619K
DKS icon
110
Dick's Sporting Goods
DKS
$17.9B
$7.43M 0.21%
143,609
-48,163
-25% -$2.65M
APD icon
111
Air Products & Chemicals
APD
$66.8B
$7.42M 0.21%
58,646
+3,753
+7% +$512K
IBB icon
112
iShares Biotechnology ETF
IBB
$9.52B
$7.37M 0.21%
59,907
+4,959
+9% +$594K
XPO icon
113
XPO
XPO
$23.4B
$7.37M 0.21%
471,511
-13,963
-3% -$226K
NVS icon
114
Novartis
NVS
$301B
$7.3M 0.2%
82,892
+4,335
+6% +$398K
TIF
115
DELISTED
Tiffany & Co.
TIF
$7.28M 0.2%
79,256
-51,313
-39% -$4.59M
XLF icon
116
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
$7.24M 0.2%
338,232
+21,966
+7% +$474K
CHE icon
117
Chemed
CHE
$7.1B
$7.16M 0.2%
54,624
-11,779
-18% -$1.46M
KKR icon
118
KKR & Co
KKR
$90.7B
$7.11M 0.2%
311,098
-22,530
-7% -$518K
UMBF icon
119
UMB Financial
UMBF
$11.1B
$6.91M 0.19%
121,220
CVS icon
120
CVS Health
CVS
$134B
$6.9M 0.19%
65,786
+14,546
+28% +$1.49M
BN icon
121
Brookfield
BN
$103B
$6.77M 0.19%
551,863
+64,983
+13% +$827K
NOV icon
122
NOV
NOV
$6.93B
$6.7M 0.19%
138,687
+24,361
+21% +$1.25M
TROW icon
123
T. Rowe Price
TROW
$25.6B
$6.68M 0.19%
85,924
+2,839
+3% +$229K
APC
124
DELISTED
Anadarko Petroleum
APC
$6.66M 0.19%
85,361
-56
-0.1% -$4.85K
BHC icon
125
Bausch Health
BHC
$2.25B
$6.65M 0.19%
29,945
+3,444
+13% +$764K

Similar funds

Oppenheimer & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Oppenheimer & Co held 1,643 positions worth $3.59B, down 2.1% from $3.67B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q2 2015 filing shows 159 new, 579 increased, 611 reduced and 173 closed positions. Its largest new stake was Southwestern Energy Company: 251,114 shares worth $5.71M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

  • Oppenheimer & Co's largest Q2 2015 buy was Southwestern Energy Company: 251,114 shares worth $5.71M.
  • Oppenheimer & Co added most to Gilead Sciences in Q2 2015, an estimated $52.5M increase.
  • Oppenheimer & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $70.4M.
  • Oppenheimer & Co fully exited Vanguard Total Bond Market in Q2 2015, selling an estimated $12.6M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.59B portfolio in Q2 2015.
  • Oppenheimer & Co opened 159 new positions and closed 173 in Q2 2015.
  • Oppenheimer & Co's portfolio value fell 2.1% quarter-over-quarter to $3.59B.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.